New AI model identifies drug candidates from existing medicines for thousands of rare diseases without current therapies ...

New study of nearly 2,000 former NFL players found that 34 percent think they have CTE, a condition it is not yet possible to ...

Harvard Medical School has become a powerful magnet of innovation and opportunity that brings people together to solve ...

The findings, published in Nature Immunology, indicate that tumors edit the activity of multiple genes to avoid immune ...

Lesbian, gay, bisexual, transgender, queer, and other sexual and gender minority people (LGBTQ+), are at greater risk of dying by suicide, of cardiovascular disease, and of a cascading list of other ...

Harvard Medical School Dean for Diversity and Community Partnership Joan Reede has been awarded the 2024 W. Montague Cobb Lifetime Achievement Award by the W. Montague Cobb/National Medical ...

Through the Therapeutics Initiative, HMS aims to accelerate the pace at which fundamental science is translated into new medicines. Image: Gretchen Ertl From the moment he wrapped up a visit to ...

Harvard Medical School researcher Joel Habener has won the 2024 Lasker~DeBakey Clinical Medical Research Award for his discovery of glucagon-like peptide-1 (GLP-1), a molecule that has become the ...

The new approach marks a major step forward in the design of AI tools to support clinical decisions in cancer diagnosis, therapy. The model uses features of a tumor’s microenvironment to forecast how ...

New research explains how herpes simplex virus can develop resistance to antiviral medicines. Study shows that movements in specific parts of a protein that enable viral replication can alter ...

A New Hampshire resident recently died from eastern equine encephalitis virus (EEE virus), and the virus is spreading across five New England states. Neither the virus nor the disease, which remains ...